Status:

COMPLETED

PENG Block and Lateral Femoral Cutaneous Nerve Block For Hip Replacement Surgery

Lead Sponsor:

Hanoi Medical University

Conditions:

POSTOPERATIVE ANALGESIA

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

Background: this study aimed to describe the pain relief outcomes after hip replacement surgery by continuous Pericapsular Nerve Group Block (PENG Block) in combination with lateral femoral cutaneous ...

Detailed Description

First, patients were explained about the study and asked to sign written informed consent if they agreed to participate in the study. Next, the patient was instructed to use the visual analogue scale ...

Eligibility Criteria

Inclusion

  • American Society of Anesthesiologists (ASA) physical status I-III.
  • Patients had hip replacement surgery.

Exclusion

  • infection of the anesthetized area.
  • coagulation disorders
  • organs dysfunction
  • allergy to anesthetics
  • did not cooperate with physicians
  • history of opioid dependence
  • inability to participate in the study

Key Trial Info

Start Date :

August 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 3 2022

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06040879

Start Date

August 1 2021

End Date

September 3 2022

Last Update

September 18 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hanoi Medical University

Hanoi, Vietnam

PENG Block and Lateral Femoral Cutaneous Nerve Block For Hip Replacement Surgery | DecenTrialz